Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In animal models, it demonstrated efficacy in reducing weight
Expression of CBFB-MYH11 fusion gene blocks differentiation of human leukemia cells
Retatrutide is being studied primarily for adults dealing with obesity or overweight conditions with related health complications
Healthcare providers increasingly rely on GLP-1 agonists in tandem with other diabetes and obesity interventions, to get better therapeutic results and steadier disease management
The medication reaches steady-state concentrations after four to five weeks of consistent dosing
US$ 23.14
US$ 22.41
US$ 27.43
US$ 28.19
US$ 21.91
